Stephenson F A, Olsen R W
J Neurochem. 1982 Dec;39(6):1579-86. doi: 10.1111/j.1471-4159.1982.tb07990.x.
Barbiturates enhance the binding of [3H]flunitrazepam to benzodiazepine receptors solubilized with the detergent 3-[(3-cholamidopropyl)-dimethylammonio]propanesulfonate (CHAPS) from bovine cortex. The enhancement by the barbiturates is seen as a decrease in the dissociation constant, KD, for specific benzodiazepine binding, with no effect on the number of binding sites. The effect of the barbiturates is facilitated by chloride ions, is concentration-dependent, and has a specificity that correlates well with the anesthetic potency of barbiturates. [3H]Flunitrazepam binding activity is stable with storage at 4 degrees C, but barbiturate enhancement of soluble benzodiazepine binding activity decayed rapidly (t 1/2 = 48 h). [3H]Muscimol binding (GABA receptor) activity was also enhanced by barbiturates. Agarose gel filtration column chromatography of the CHAPS-solubilized receptor proteins showed the same elution profile as receptors solubilized with sodium deoxycholate, and enhancement by barbiturates was observed for both the benzodiazepine and GABA binding activities.
巴比妥类药物可增强[3H]氟硝西泮与用去污剂3-[(3-胆酰胺丙基)-二甲基铵]丙烷磺酸盐(CHAPS)从牛脑皮层中溶解出来的苯二氮卓受体的结合。巴比妥类药物的增强作用表现为特异性苯二氮卓结合的解离常数KD降低,而对结合位点的数量没有影响。巴比妥类药物的作用受氯离子促进,具有浓度依赖性,且其特异性与巴比妥类药物的麻醉效力密切相关。[3H]氟硝西泮结合活性在4℃储存时稳定,但巴比妥类药物对可溶性苯二氮卓结合活性的增强作用迅速衰减(t1/2 = 48小时)。[3H]蝇蕈醇结合(GABA受体)活性也被巴比妥类药物增强。用CHAPS溶解的受体蛋白进行琼脂糖凝胶过滤柱层析,其洗脱图谱与用脱氧胆酸钠溶解的受体相同,并且观察到巴比妥类药物对苯二氮卓和GABA结合活性均有增强作用。